TY - JOUR
T1 - Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations
AU - Nakov, R.
AU - Suhr, O. B.
AU - Ianiro, Gianluca
AU - Kupcinskas, J.
AU - Segal, J. P.
AU - Dumitrascu, D. L.
AU - Heinrich, H.
AU - Mikolasevic, I.
AU - Stojkovic-Lalosevic, M.
AU - Barbov, I.
AU - Sarafov, S.
AU - Tournev, I.
AU - Nakov, V.
AU - Wixner, J.
PY - 2021
Y1 - 2021
N2 - Transthyretin amyloid (ATTR) amyloidosis is an adult-onset, rare systemic disorder characterized by the accumulation of misfolded fibrils in the body, including the peripheral nerves, the heart and the gastrointestinal tract. Gastrointestinal manifestations are common in hereditary (ATTRv) amyloidosis and are present even before the onset of the polyneuropathy in some cases. Delays in diagnosis of ATTRv amyloidosis with gastrointestinal manifestations commonly occur because of fragmented knowledge among gastroenterologists and general practitioners, as well as a shortage of centers of excellence and specialists dedicated to disease management. Although the disease is becoming well-recognized in the societies of Neurology and Cardiology, it is still unknown for most gastroenterologists. This review presents the recommendations for ATTRv amyloidosis with gastrointestinal manifestations elaborated by a working group of European gastroenterologists and neurologists, and aims to provide digestive health specialists with an overview of crucial aspects of ATTRv amyloidosis diagnosis to help facilitate rapid and accurate identification of the disease by focusing on disease presentation, misdiagnosis and management of gastrointestinal symptoms.
AB - Transthyretin amyloid (ATTR) amyloidosis is an adult-onset, rare systemic disorder characterized by the accumulation of misfolded fibrils in the body, including the peripheral nerves, the heart and the gastrointestinal tract. Gastrointestinal manifestations are common in hereditary (ATTRv) amyloidosis and are present even before the onset of the polyneuropathy in some cases. Delays in diagnosis of ATTRv amyloidosis with gastrointestinal manifestations commonly occur because of fragmented knowledge among gastroenterologists and general practitioners, as well as a shortage of centers of excellence and specialists dedicated to disease management. Although the disease is becoming well-recognized in the societies of Neurology and Cardiology, it is still unknown for most gastroenterologists. This review presents the recommendations for ATTRv amyloidosis with gastrointestinal manifestations elaborated by a working group of European gastroenterologists and neurologists, and aims to provide digestive health specialists with an overview of crucial aspects of ATTRv amyloidosis diagnosis to help facilitate rapid and accurate identification of the disease by focusing on disease presentation, misdiagnosis and management of gastrointestinal symptoms.
KW - differential diagnosis
KW - rare disease
KW - transthyretin amyloidosis
KW - differential diagnosis
KW - rare disease
KW - transthyretin amyloidosis
UR - https://publicatt.unicatt.it/handle/10807/310840
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85103682985&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103682985&origin=inward
U2 - 10.1097/MEG.0000000000002030
DO - 10.1097/MEG.0000000000002030
M3 - Article
SN - 0954-691X
VL - 33
SP - 613
EP - 622
JO - European Journal of Gastroenterology and Hepatology
JF - European Journal of Gastroenterology and Hepatology
IS - 5
ER -